ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada · Delayed Price · Currency is CAD 0.7100
+0.0400 (5.97%)
Aug 12, 2025, 4:00 PM EDT
Paramount Global Revenue
ZYUS Life Sciences had revenue of 114.00K CAD in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 481.00K, up 24.29% year-over-year. In the year 2024, ZYUS Life Sciences had annual revenue of 481.00K with 37.04% growth.
Revenue
481.00K
Revenue Growth
+24.29%
P/S Ratio
115.15
Revenue / Employee
n/a
Employees
n/a
Market Cap
55.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 481.00K | 130.00K | 37.04% |
| Dec 31, 2023 | 351.00K | 53.00K | 17.79% |
| Dec 31, 2022 | 298.00K | 91.00K | 43.96% |
| Dec 31, 2021 | 207.00K | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.57B |
| Curaleaf Holdings | 1.75B |
| Sienna Senior Living | 896.45M |
| dentalcorp Holdings | 1.62B |
| Trulieve Cannabis | 1.62B |
| WELL Health Technologies | 990.34M |
| Cronos Group | 177.69M |
| Extendicare | 1.51B |